Related Experiment Videos
An abdominally placed, implantable left ventricular assist system for long-term use
1National Cardiovascular Center Research Institute, Osaka, Japan.
Summary
A new implantable left ventricular assist system (LVAS) demonstrated stable hemodynamic support for over 8 weeks in goats. This system, using electrical impedance for monitoring, shows promise for long-term clinical use.
Area of Science:
- Biomedical Engineering
- Cardiovascular Devices
- Implantable Systems
Background:
- Heart failure necessitates advanced circulatory support.
- Existing left ventricular assist systems (LVAS) face challenges in long-term reliability and monitoring.
- Development of robust, implantable LVAS is crucial for managing end-stage heart failure.
Purpose of the Study:
- To develop and evaluate a novel implantable left ventricular assist system (LVAS) for long-term use.
- To assess the efficacy of electrical impedance monitoring for continuous pump performance assessment.
- To validate the system's hemodynamic stability and safety in an animal model.
Main Methods:
- An implantable blood pump made of segmented polyether polyurethane was designed and positioned in the abdominal wall.
- A percutaneous drive line connected the pump to a portable control drive unit (CDU) with integrated impedance monitoring.
- The LVAS was implanted in six adult goats, connecting the left ventricular apex to the descending aorta, without antithrombogenic agents.
Main Results:
- The LVAS provided stable hemodynamic conditions for over 8 weeks in goats.
- Pump output (Op) estimated by electrical impedance showed a linear correlation with electromagnetic flowmeter measurements.
- No significant hematologic abnormalities, infections, or thromboembolic events were observed, indicating good biocompatibility and safety.
Conclusions:
- The developed implantable left ventricular assist system (LVAS) is effective for long-term hemodynamic support.
- Electrical impedance monitoring provides reliable estimation of pump performance and control.
- This LVAS demonstrates significant potential for future clinical application in heart failure patients.